$0.32
2.23% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
US09061H3075
Symbol
BMRA

Biomerica, Inc. Stock price

$0.32
+0.03 8.81% 1M
-0.31 48.72% 6M
-0.93 74.32% YTD
-0.59 64.73% 1Y
-4.75 93.67% 3Y
-2.65 89.19% 5Y
-0.53 62.24% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.01 2.23%
ISIN
US09061H3075
Symbol
BMRA
Sector

Key metrics

Market capitalization $5.40m
Enterprise Value $3.29m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.60
P/S ratio (TTM) P/S ratio 0.98
P/B ratio (TTM) P/B ratio 1.01
Revenue growth (TTM) Revenue growth 1.71%
Revenue (TTM) Revenue $5.51m
EBIT (operating result TTM) EBIT $-6.50m
Free Cash Flow (TTM) Free Cash Flow $-5.06m
Cash position $2.82m
EPS (TTM) EPS $-0.37
Short interest 3.60%
Show more

Is Biomerica, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Biomerica, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Biomerica, Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Biomerica, Inc.:

Buy
100%

Financial data from Biomerica, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Aug '24
+/-
%
5.51 5.51
2% 2%
100%
- Direct Costs 5.02 5.02
12% 12%
91%
0.49 0.49
46% 46%
9%
- Selling and Administrative Expenses 5.29 5.29
1% 1%
96%
- Research and Development Expense 1.32 1.32
22% 22%
24%
-6.13 -6.13
1% 1%
-111%
- Depreciation and Amortization 0.38 0.38
9% 9%
7%
EBIT (Operating Income) EBIT -6.50 -6.50
2% 2%
-118%
Net Profit -6.16 -6.16
1% 1%
-112%

In millions USD.

Don't miss a Thing! We will send you all news about Biomerica, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Biomerica, Inc. Stock News

Neutral
GlobeNewsWire
5 days ago
IRVINE, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical technology company, announces they have recently received three patent notices of allowance covering technology and methods for treating Gastroesophageal Reflux Disease (“GERD”), Crohn's Disease, and Ulcerative Colitis using its proprietary inFoods® Technology. These patents apply to countries ...
Neutral
GlobeNewsWire
19 days ago
IRVINE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a leading global provider of advanced medical diagnostics, announced that it has been granted an additional 180-day compliance period from the Nasdaq Stock Market LLC ("Nasdaq") to meet the minimum $1.00 per share bid price requirement for continued listing on the Nasdaq Capital Market. This extension allows Biome...
Neutral
GlobeNewsWire
27 days ago
IRVINE, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a leading global provider of advanced medical diagnostics, is excited to announce a major enhancement to its inFoods® IBS platform. US consumers can now seamlessly order the inFoods® IBS test directly from infoodsibs.com and consequently collect a sample in the comfort of their home. As part of this ordering proce...
More Biomerica, Inc. News

Company Profile

Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. It focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, United States, Asia, South America, Middle East, and Other Foreign. The company was founded in September 1971 and is headquartered in Irvine, CA.

Head office United States
CEO Zackary Irani
Employees 64
Founded 1971
Website www.biomerica.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today